← Back to Clinical Trials
Recruiting NCT07578909

NCT07578909 Retro Walking With and Without Bosu Ball for Balance and Mobility in Hearing Impaired Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07578909
Status Recruiting
Phase
Sponsor Riphah International University
Condition Hearing Impaired Children
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2026-04-15
Primary Completion 2026-07-05

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Retro walkingBosu Ball

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2026-04-15 with a primary completion date of 2026-07-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

his randomized controlled trial aims to evaluate the effects of retro walking with and without BOSU ball training on balance and mobility in hearing-impaired children aged 8-12 years. A total of 24 participants will be divided into experimental and control groups. The experimental group will receive retro walking along with BOSU ball training, while the control group will perform retro walking only for 8 weeks. Balance and mobility will be assessed using the Pediatric Balance Scale, Timed Up and Go Test, and One-Leg Stance Test. Data will be collected from specialized schools in Lahore and analyzed using SPSS 27. Ethical approval will be obtained prior to study commencement.

Eligibility Criteria

Inclusion Criteria: * Age 8 to 12 years. * Children with hearing loss in right and left ear (bilateral). * Children with hearing-impaired intensity over 61 dB. * Both genders will be included. * Balance cut off value \<45 on pediatrics balance scale. Exclusion Criteria: * Presence of neurologic disease. * Hyperactivity and vision problems. * Have any musculoskeletal disorders. * Children with cochlear implant. * Children with leg length discrepancy

Contact & Investigator

Central Contact

Imran Amjad, phD

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Salma Kanwal, MS-PT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07578909 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Hearing Impaired Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07578909 currently recruiting?

Yes, NCT07578909 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07578909 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07578909 clinical trial?

NCT07578909 is sponsored by Riphah International University. The principal investigator is Salma Kanwal, MS-PT at Riphah International University. The trial plans to enroll 24 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology